|
|||||
|
|
Adverse events related to biologicals used for patients with multiple sclerosis: a comparison between information originating from regulators and information originating from the scientific community |
|
| Authors: | L A Minnema T J Giezen T C G Egberts H G M Leufkens H Gardarsdottir |
| Abstract: | |
| Keywords: | adverse events biologicals European Public Assessment Report multiple sclerosis scientific publication |